Compare DMRA & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | WEN |
|---|---|---|
| Founded | 2011 | 1969 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2000 |
| Metric | DMRA | WEN |
|---|---|---|
| Price | $24.76 | $7.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 22 |
| Target Price | ★ $43.00 | $8.84 |
| AVG Volume (30 Days) | 398.6K | ★ 20.2M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 8.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $2,176,891,000.00 |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | N/A | $0.94 |
| P/E Ratio | ★ N/A | $61.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.50 | $6.07 |
| 52 Week High | $28.76 | $12.04 |
| Indicator | DMRA | WEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 56.38 |
| Support Level | $22.71 | $6.62 |
| Resistance Level | $27.70 | $8.54 |
| Average True Range (ATR) | 2.23 | 0.54 |
| MACD | 0.41 | 0.09 |
| Stochastic Oscillator | 85.36 | 49.50 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.